Background/Objectives: Epidermolysis bullosa is a group of diseases caused by
| INTRODUCTION Epidermolysis bullosa (EB) is an inherited mechanobullous disease
resulting in blistering at sites of trauma. EB simplex (EBS) is the most common subtype and results in blistering within or above the epidermal basal layer. It is most commonly caused by autosomal dominant mutations in keratin 5 (KRT5) or keratin 14 (KRT14). 1 The protein products of these genes, keratin 5 (K5) and keratin 14 (K14), are paired intermediate filaments expressed in basal keratinocytes that contribute to mechanical stability. 2 Mutations in either of these genes result in altered proteins, causing instability of the cytoskeletal structure and blistering at pressure sites.
A range of severity is observed in EBS, from localized skin fragility to severe generalized mucocutaneous blistering. 3 EBS-generalized severe (EBS-GS, formerly known as Dowling-Meara) is the most severe phenotype, characterized by generalized clustered blisters, severe palmoplantar keratoderma, dystrophic nails, and oral ulcerations. 3 EBS-GS is most often caused by substitution mutations within the highly conserved 1A or 2B domains of KRT5 and KRT14. 4 There are currently 56 described causative mutations for EBS-GS in KRT5 and KRT14. 4 Keratins are heterodimeric proteins composed of a head, central rod domain, and tail region. 5, 6 The central rod domain is comprised of several subunits. Two subunits, 1A (or helix initiation peptide, HIP) and 2B (helix termination peptide, HTP), located at the ends of the central rod domain, are crucial for the creation of functional keratin filaments. 7 Mutations in these regions interfere with early stages of filament elongation 8 and are mutational "hot spots" in most hereditary keratin disorders. 7 The change from guanine to adenine at nucleotide position 1429 in the coding DNA sequence within the HTP of KRT5 results in a glutamic acid (Glu) to lysine (Lys) substitution at position 477 on K5 (p.Glu477Lys) and has been reported as a causative mutation for fatal or severe and generalized EBS. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] We describe six patients with an identical heterozygous c.1429 G>A (p.Glu477Lys) mutation in exon 7 of KRT5, located within the 2B domain of K5. We report these cases to elucidate the phenotype associated with this genotype. We also perform in silico modeling to understand the predicted structural changes this keratin mutation may cause and to discuss possible mechanisms by which this mutation confers a severe phenotype.
| MATERIALS AND METHODS
Of the six cases of EBS-GS caused by the K5 p.Glu477Lys substitution identified, two were from the United States and one each was from
Italy, Germany, Finland, and Chile. Institutional review board approval was exempted. Mutational analysis was performed using Sanger sequencing, and the KRT5 mutation was numbered according to the GenBank accession number NM_000424.3 and NP_000415.2 for mRNA and protein, respectively. None of the patients identified had a known family history of EB, and all were diagnosed around birth.
We performed in silico modeling of the K5-K14 coil 2B complex using CCBuilder 20 and rendered with Pymol (Schrodinger, LLC).
| RESULTS

| Patient characteristics
Brief descriptions of each patient are listed in Table 1 .
Case 1 was the first child of nonconsanguineous parents. He had extensive aplasia cutis at birth and generalized herpetiform blistering.
He had severe oral blistering and required feeding support with a gastrostomy tube. He had epiglottal malacia in infancy that improved with age. He developed palmar and finger contraction, fusion of toes, severely dystrophic nails, and moderate palmoplantar keratoderma.
He had delays in gross and fine motor development but normal cognitive development. He has continuously had severe and extensive blistering ( Figure 1A ,B Genetic analysis of both parents showed wild-type genotypes.
Case 6 was the second child of nonconsanguineous parents. At birth, she had aplasia cutis on the lower extremities; blistering mainly on the hands, legs, and buttocks; oral blistering; generalized milia; and absent or dystrophic nails. She required gastrostomy and tracheostomy placement, which have since been removed. For the first 6 months, she received monthly IVIg infusions due to recurrent severe infections and hypogammaglobulinemia. From infancy and currently during childhood, she has had mild blistering and palmoplantar hyperkeratosis and reticulated pigmentation. She had major delays in speech, motor, cognitive, and social skills, as well as failure to thrive.
Mutational analysis revealed a heterozygous c.1429 G>A (p.Glu477Lys) mutation in exon 7 of KRT5. Genetic analysis of both parents showed wild-type genotypes.
| In silico modeling
Regarding the nature of the mutation, p.Glu477Lys predicts the replacement of an acidic, negatively charged residue (Glu) with a basic, positively charged residue (Lys) at position 477 of K5. In order to provide insight into the consequences of this change, we performed in silico modeling of the K5-K14 coil 2B complex using CCBuilder 20 and rendered with Pymol (Schrodinger, LLC, New York, NY; Figure 3) . The predicted surface model based on the van der Waals radius of atoms of the coiled-coil structure of 2B domains of K5 and K14 ( Figure 3A ) is close to the published model based on crystallographic data. 21 In silico model of the K5 p.Glu477Lys mutation predicts a local conformational change of arginine (Arg)
471, predicted to form a hydrogen bond with tyrosine (Tyr) 415 of K14 and an electrostatic interaction with Glu411 of K14. 22 It also predicts a conformational change of leucine (Leu) 474 of K5 (Fig- ure 3B,C), which is predicted to form a hydrophobic interaction with Leu419 of K14. 22 Moreover, the local surface charge of the K5-K14 coil 2B complex is predicted to display a strong positive charge at its amino terminus and a strong negative charge at its carboxy terminus. 22 Our in silico model reproduces a similar surface charge distribution, and mutation p.Glu477Lys is predicted to strongly modify the local surface charge of the heterodimer ( Figure 3D ).
| DISCUSSION
All six patients with the p.Glu477Lys mutation in K5 displayed EBS with severe generalized blistering and aplasia cutis and required intensive care unit admissions after birth ( indicates that the nonhelical head domain of K5 may be implicated in melanosome transport. How this may relate to our patients' mutation and phenotype remains to be elucidated.
The common features of this condition describe a unique and particularly severe EBS phenotype, which probably results from both the localization and nature of the glutamic acid to lysine substitution at position 477 on K5. Glu477 is located in the last position of the HTP sequence (469-477) of the rod domain of K5. 8, 9 This sequence is nearly perfectly conserved among all intermediate filament proteins, and like the HIP in the 1A domain, is known to play an essential role in keratin filament assembly. 8 These two sequences tolerate no modification and account for the majority of EBS-GS mutations. 4 Keratin rod domains have a coiled-coil configuration due to heptad repeats ("abcdefg"), which form a repeated pattern of charged and 42 was used to calculate the potential map of the wild-type and mutant K14-K5 coil 2B complexes. Structures were prepared for APBS calculations using PDB2PQR software. 43 The calculated electrostatic surface potentials are similar to what have been calculated using crystallographic data, 22 in particular the strong positive charge potential at the N-terminus and a strong negative charge potential at the C-terminus. Note the strong change in local electrostatic surface potential at the position of the mutation from glutamic acid 477 (E477) to lysine 477 (K477) (-7kTe-1 to 7kTe-1). For all images, rendered using Pymol 1.7.7.1 (Schrodinger, LLC) hydrophobic amino acid residues, where residues at positions "a"
and "d" are often hydrophobic and buried. 7 Therefore, their defects usually have severe consequences for filament formation. In contrast, the charged surface-exposed residues ("b," "c," or "f"), which are in direct contact with the cytoplasm, have usually less deleterious effects when mutated. Glu477 is predicted to be located at the "d"
position of the last heptad repeat of the 2B domain of K5. 22 Residues at the "d" position of K5 are predicted to interact with residues at the "a" position of the corresponding heptad repeat of K14.
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Glu477 is thus predicted to interact with Leu419 located at the "a"
position of K14, but the "d" positions in K5 are usually occupied by hydrophobic residues (such as leucine and alanine), and no glutamic acid residue is present in any "d" position in the heptads of K5 or K14 2B domains. 22 Moreover, glutamic acid is a charged residue mainly found at position "g" (and at a lesser frequency at positions "b," "c," and "e"). 21 In fact, radiograph crystallography data indicate that K5-K14 features more asymmetric salt bridges (between "g" and "e" positions) and fewer hydrophobic interaction clusters than homodimeric intermediate filaments. In addition, the HTP region of K5 features a dense array of nonhydrophobic interactions between K5 and K14 strands. 22 In particular, arginine 471 of K5 interacts with Glu411 and Tyr415 of K14 through an electrostatic interaction and a hydrogen bond, respectively, while Leu474 of K5 (instead of Glu477) probably interacts with Leu419 of K14 through a hydrophobic interaction. 22 Our in silico modeling analysis suggests that local changes are likely to modify the strength of these interactions and impair dimer and tetramer stability ( Figure 3B,C) . Additionally, our model of mutated p.Glu477Lys predicts a strong modification of the local surface charge of the heterodimer ( Figure 3D ). Such a modification of the electrostatic surface potential may also further impair the dimerization initiation, the axial alignment, and the lateral assembly of keratin coiled-coil dimers during filament assembly, contributing to mechanical instability. 22 Interestingly, Hut et al 35 reported a case of EBS-GS due to a leucine to glutamine substitution at position 419 of K14 (Leu419Gln), which is predicted to be located at position "a" of the last heptad repeat of K14. Though the presentation was less severe than our cases with K5 p.Glu477Lys, this supports the notion that amino acids located at "a" or "d" positions of the last heptad repeat of 2B and in the HIP region of K5 of K14 are of particular importance. It has been suggested that K14 mutations result in less severe phenotypes due to compensation by similar keratins, while no such compensation for mutated K5 has been demonstrated, 36 potentially explaining why the K14 p.Leu419Gln mutation resulted in a less severe phenotype than K5 p.Glu477Lys, despite those two residues being predicted to interact.
In addition to the p.Glu477Lys mutation in K5 reported here and by others, two other missense mutations at the 477 position in exon 7 have been reported. 10, 37 Schumann et al 37 describe a heterozygote for p.Glu477Asp. This mutation replaces an acidic, negatively charged amino acid (glutamic acid) by another acidic, negatively charged amino acid (asparagine), which may result in less drastic changes in dimer and tetramer formation and a less severe phenotype. The patient described by Hamada et al 10 had localized EBS with primary palmoplantar blistering beginning in early childhood.
The K5 p.Glu477Gly mutation identified in this patient predicts a glutamic acid to glycine substitution. Because glycine is a small and amphoteric amino acid residue, this substitution may be less deleterious than glutamic acid to lysine, despite being at the same location.
It is not clear why several of the patients in our series had severe developmental delays beyond what might be expected for a chronically ill child. However, several investigators have discovered that keratins exert variable signaling functions unrelated to their mechanical ones. [38] [39] [40] [41] We cannot say for certain that this K5 p.Glu477Lys mutation plays a causative role in their developmental delays, but perhaps with further research a relationship may become clear.
In conclusion, we describe six patients with an identical heterozygous p.Glu477Lys mutation in keratin 5 who display a consistent, severe, and sometimes fatal phenotype of EBS-GS characterized by severe generalized blistering, palmoplantar keratoderma, onychodystrophy, and distinctive, possibly pathognomonic, reticulated skin pattern. Early recognition of the phenotypic features of this genotype can improve care of these sick neonates.
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